Incoming FDA Commissioner Ned Sharpless used his first official talk to ensure we all know he’s not looking to tear up Scott Gottlieb’s legacy.

Charles River Labs and the CHDI Foundation have signed a five-year extension for their Huntington’s disease work.

Concerto HealthAI has inked its second real-world data collaboration with a Big Pharma company in as many weeks.

WuXi AppTec has hired Frederick Hausheer, M.D., as it looks to mine his clinical trial expertise for its boosted drug development offerings.

Looking to boost its offerings in central nervous system trials, Evolution Research Group has bought up New York-based Finger Lakes Clinical Research.

After a number of pacts and buyouts over the past few years, Charles River Labs is cutting staff at one of its California sites.

LabCorp tapped Mission Bio to provide single-cell DNA analysis in a collaboration with its Covance drug development arm.

Bristol-Myers Squibb has tapped Concerto HealthAI for a multiyear, real-world data project covering a range of different cancers.